Liver Enzymes After Acetaminophen Error in Critically Ill Children: A Cohort Study
Abstract ObjectivesDrug-associated harm is common but difficult to detect in the hospital setting. In critically ill children, we sought to evaluate drug-associated hepatic injury following enteral acetaminophen error; defined as acetaminophen dosing that exceeds daily maximum recommendations.DesignRetrospective cohort study.SettingTwo pediatric intensive care units within a pediatric hospital center.PatientsChildren (<18 years of age) admitted to the pediatric and cardiac intensive care unit between January 2008 and January 2018, and receiving enteral acetaminophen. We defined acetaminophen dosing error as exceeding daily acetaminophen dosing by > 10% the upper limit of maximum recommended dose for weight and age (>82.5mg/kg/day or > 4400mg/day).Main ResultsWe included 14,146 admissions, who received 147,485 doses of acetaminophen. Acetaminophen dosing errors occurred 1 in every 9.5 patient-days on acetaminophen. ALT and AST decreased significantly over the course of ICU admission (p<0.0001). In patients with acetaminophen errors, ALT and AST measured in the 24 to 96 hours post error were not significantly different than when measured outside this window. A sensitivity analysis using >100 mg/kg/day as the upper daily acetaminophen error cut-off did not reveal any subsequent significant increase in ALT or ALT in the 24 to 96-hour post-error window, compared to measurements taken outside the window.ConclusionsAlthough the administration of acetaminophen in critically ill children frequently exceeds the daily recommended limit and vigilance is needed, we did not find any associated increase in liver transaminases following acetaminophen errors.